Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12months

results from the FIN-ERA cohort

T. Rannio, J. Asikainen, P. Hannonen, T. Yli-Kerttula, P. Ekman, L. Pirilä, L. Kuusalo, M. Mali, M. Puurtinen-Vilkki, S. Kortelainen, J. Paltta, K. Taimen, M. Kauppi, K. Laiho, S. Nyrhinen, H. Makinen, P. Isomaki, T. Uotila, K. Aaltonen, H. Kautiainen & 1 others T. Sokka

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalScandinavian Journal of Rheumatology
Volume46
Issue number6
Pages (from-to)425-431
Number of pages7
ISSN0300-9742
DOIs
Publication statusPublished - 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • NECROSIS-FACTOR INHIBITORS
  • COMBINATION THERAPY
  • CLINICAL-PRACTICE
  • ESPOIR COHORT
  • TRIALS
  • CRITERIA
  • OUTCOMES
  • 3121 Internal medicine
  • 317 Pharmacy

Cite this

Rannio, T. ; Asikainen, J. ; Hannonen, P. ; Yli-Kerttula, T. ; Ekman, P. ; Pirilä, L. ; Kuusalo, L. ; Mali, M. ; Puurtinen-Vilkki, M. ; Kortelainen, S. ; Paltta, J. ; Taimen, K. ; Kauppi, M. ; Laiho, K. ; Nyrhinen, S. ; Makinen, H. ; Isomaki, P. ; Uotila, T. ; Aaltonen, K. ; Kautiainen, H. ; Sokka, T. / Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12months : results from the FIN-ERA cohort. In: Scandinavian Journal of Rheumatology. 2017 ; Vol. 46, No. 6. pp. 425-431.
@article{a253f62138c640e7bc90c3b70f8c2183,
title = "Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12months: results from the FIN-ERA cohort",
keywords = "NECROSIS-FACTOR INHIBITORS, COMBINATION THERAPY, CLINICAL-PRACTICE, ESPOIR COHORT, TRIALS, CRITERIA, OUTCOMES, 3121 Internal medicine, 317 Pharmacy",
author = "T. Rannio and J. Asikainen and P. Hannonen and T. Yli-Kerttula and P. Ekman and L. Piril{\"a} and L. Kuusalo and M. Mali and M. Puurtinen-Vilkki and S. Kortelainen and J. Paltta and K. Taimen and M. Kauppi and K. Laiho and S. Nyrhinen and H. Makinen and P. Isomaki and T. Uotila and K. Aaltonen and H. Kautiainen and T. Sokka",
year = "2017",
doi = "10.1080/03009742.2016.1266029",
language = "English",
volume = "46",
pages = "425--431",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "TAYLOR & FRANCIS LTD",
number = "6",

}

Rannio, T, Asikainen, J, Hannonen, P, Yli-Kerttula, T, Ekman, P, Pirilä, L, Kuusalo, L, Mali, M, Puurtinen-Vilkki, M, Kortelainen, S, Paltta, J, Taimen, K, Kauppi, M, Laiho, K, Nyrhinen, S, Makinen, H, Isomaki, P, Uotila, T, Aaltonen, K, Kautiainen, H & Sokka, T 2017, 'Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12months: results from the FIN-ERA cohort', Scandinavian Journal of Rheumatology, vol. 46, no. 6, pp. 425-431. https://doi.org/10.1080/03009742.2016.1266029

Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12months : results from the FIN-ERA cohort. / Rannio, T.; Asikainen, J.; Hannonen, P.; Yli-Kerttula, T.; Ekman, P.; Pirilä, L.; Kuusalo, L.; Mali, M.; Puurtinen-Vilkki, M.; Kortelainen, S.; Paltta, J.; Taimen, K.; Kauppi, M.; Laiho, K.; Nyrhinen, S.; Makinen, H.; Isomaki, P.; Uotila, T.; Aaltonen, K.; Kautiainen, H.; Sokka, T.

In: Scandinavian Journal of Rheumatology, Vol. 46, No. 6, 2017, p. 425-431.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12months

T2 - results from the FIN-ERA cohort

AU - Rannio, T.

AU - Asikainen, J.

AU - Hannonen, P.

AU - Yli-Kerttula, T.

AU - Ekman, P.

AU - Pirilä, L.

AU - Kuusalo, L.

AU - Mali, M.

AU - Puurtinen-Vilkki, M.

AU - Kortelainen, S.

AU - Paltta, J.

AU - Taimen, K.

AU - Kauppi, M.

AU - Laiho, K.

AU - Nyrhinen, S.

AU - Makinen, H.

AU - Isomaki, P.

AU - Uotila, T.

AU - Aaltonen, K.

AU - Kautiainen, H.

AU - Sokka, T.

PY - 2017

Y1 - 2017

KW - NECROSIS-FACTOR INHIBITORS

KW - COMBINATION THERAPY

KW - CLINICAL-PRACTICE

KW - ESPOIR COHORT

KW - TRIALS

KW - CRITERIA

KW - OUTCOMES

KW - 3121 Internal medicine

KW - 317 Pharmacy

U2 - 10.1080/03009742.2016.1266029

DO - 10.1080/03009742.2016.1266029

M3 - Article

VL - 46

SP - 425

EP - 431

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - 6

ER -